US Supreme Court Agrees to Hear Case , That Could Impact Nationwide , Abortion Pill Access.<br />On December 13, the United States Supreme Court <br />agreed to hear arguments in a case regarding <br />the most widely-used abortion pill in the nation.<br />'The Guardian' reports that it will be the first <br />time the highest court hears an abortion rights <br />case since overturning Roe v. Wade in 2022.<br />The case could determine the future of access to <br />the pill and the Federal Drug Administration's <br />authority to regulate a number of medications.<br />Last year, the Alliance for Hippocratic Medicine, <br />a group of anti-abortion organizations and <br />doctors, filed a federal lawsuit against the FDA.<br />The lawsuit accuses the agency of overstepping <br />its authority by approving mifepristone, one of two <br />drugs commonly used in abortions, in 2000.<br />In April, a federal judge in Texas suspended <br />the FDA's approval of mifepristone and <br />had the medication pulled from the market.<br />In August, the U.S. Court of Appeals for <br />the Fifth Circuit ruled that the FDA should <br />significantly restrict access to mifepristone. .<br />In response, the Biden administration and Danco <br />Laboratories, the manufacturer of mifepristone, <br />called on the Supreme Court to hear the case.<br />In response, the Biden administration and Danco <br />Laboratories, the manufacturer of mifepristone, <br />called on the Supreme Court to hear the case.<br />The Supreme Court paused lower-court rulings until justices <br />issue a judgement, resulting in mifepristone remaining <br />widely available in states where abortions are legal.<br />The Supreme Court paused lower-court rulings until justices <br />issue a judgement, resulting in mifepristone remaining <br />widely available in states where abortions are legal.<br />However, 'The Guardian' reports that the outcome <br />of the case would impact all 50 states, <br />including those with protected abortion rights.
